GLAXOSMITHKLINE is UK based multi-national Pharmaceuticals business and it has a broad portfolio of innovative and established medicines. GSK currently focus on developing new medicines in respiratory, HIV, oncology and immuno-inflammation; with an R&D approach focused on science related to the immune system, use of genetics and advanced technologies. Headquarters is in UK.
In 2021 GSK delivered 1.7 billion medicines, over 767 million vaccines* and 3.7 billion consumer healthcare products.